Contineum Therapeutics, Inc. (CTNM) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of Contineum Therapeutics, Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTNM
Contineum Therapeutics, Inc.
$12.58HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
OVID
Ovid Therapeutics Inc.
$2.41HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — CTNM vs OVID
growth of $100 · dividends reinvested · last 2yCTNM -17.4% (-9.1%/yr)OVID -28.0% (-15.1%/yr)CTNM compounded faster over this window
CTNM OVID
CTNM vs OVID: by the numbers
- •CTNM is the larger company ($473M vs $449M market cap).
- •Both run net losses; CTNM's is the smaller (0.00% vs -2178.90% net margin).
Metrics side by side
Valuation
| Metric | CTNM | OVID |
|---|---|---|
| P/S ratio | N/A | 283.56 |
| P/B ratio | 1.97 | 2.14 |
Profitability
| Metric | CTNM | OVID |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -585.20% |
| Net margin | 0.00% | -2178.90% |
| ROE | -24.02% | -16.43% |
| ROIC | -27.22% | -26.29% |
Growth (annualized)
| Metric | CTNM | OVID |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -62.76% |
| Total return CAGR (5Y) | N/A | -6.98% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.